Publications focused on the possibility of detecting mutated protein such as EGFR, BRAF... directly on lung cancer tissue by mutation-specific IHC with 92% of sensitivity which is comparable to DNA sequencing [15, 18]. This evidence concerns the gene EGFR and lung carcinoma.